These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8868116)

  • 21. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia.
    Al-Kubaisy WA; Al-Naib KT; Habib M
    East Mediterr Health J; 2006; 12(1-2):204-10. PubMed ID: 17037239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
    Bagga PK; Singh SP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic.
    Haidar NA
    Saudi Med J; 2002 Sep; 23(9):1090-4. PubMed ID: 12370719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seroconversion of hepatitis C in blood donors].
    Pascuccio MS; Gendler SA; Carnevali L; Fuse V
    Medicina (B Aires); 2007; 67(6 Pt 2):771-2. PubMed ID: 18422076
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B and C in Egypt and Africa.
    Attia MA
    Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of types of hepatitis C virus in Spanish blood donors: results of a state-based multicenter study. Spanish Group for the Study of Blood Donors with Risk of HCV Transmission].
    León P; López JA; Amela C; Elola C; Echevarría JM
    Enferm Infecc Microbiol Clin; 1999 Nov; 17(9):448-53. PubMed ID: 10614078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis C virus infection in blood bank donors at the Hospital Nacional Cayetano Heredia (1998 - 2002)].
    Pinto Valdivia JL; Vidal Escudero J; Bussalleu A; Huerta Mercado Tenorio J; Ramírez Vergara D; Valdivia R J; de los Ríos S R
    Rev Gastroenterol Peru; 2003; 23(1):22-8. PubMed ID: 12768211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
    Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of hepatitis c in blood donors in Niamey].
    Mamadou S; Gragnic G; Kabo R; Salami H; Boulkassoum Z
    Bull Soc Pathol Exot; 1997; 90(2):74. PubMed ID: 9289255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.